HIV/AIDS Headlines

Once-Daily Single-Tablet HIV Treatment Safe, Effective in Children

Once-Daily Single-Tablet HIV Treatment Safe, Effective in Children

The single tablet regimen is a combination of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide.

New Single-Tablet Treatment for HIV Infection Advantageous to Standard Therapy

New Single-Tablet Treatment for HIV Infection Advantageous to Standard Therapy

Virological response, efficacy, noninferiority, and tolerability were tested for bictegravir, emtricitabine, and tenofovir alafenamide vs dolutegravir, abacavir, and lamivudine.

Single Measure Viral Load Estimates of HIV Suppression in 2014

Single Measure Viral Load Estimates of HIV Suppression in 2014

Single measures of viral load can overestimate how many individuals with HIV infection have viral suppression.

Bone Loss and Fracture Risk in Patients With HIV: What We Know So Far

Bone Loss and Fracture Risk in Patients With HIV: What We Know So Far

In addition to prevention measures, switching off the ARTs associated with bone loss and administering intravenous bisphosphonate, a bone resorption inhibitor, can be an effective strategy for preventing bone loss seen in HIV-infected individuals.

Point-of-Care Tests for HIV and T pallidum Infections: Utility of Smartphone-Based Electronic Reader

Point-of-Care Tests for HIV and T pallidum Infections: Utility of Smartphone-Based Electronic Reader

A smartphone-based electronic reader with dual point of care tests were evaluated in the detection of antibodies to T pallidum and HIV.

Offering Rapid HIV Testing in EDs Increase Testing Rates

Offering Rapid HIV Testing in EDs Increase Testing Rates

Rapid HIV testing offered to patients in addition to a clinician consultation increases the testing rate in the emergency department.

Viral Load Rebound Seen After HIV Suppression in Pregnancy

Viral Load Rebound Seen After HIV Suppression in Pregnancy

Women achieving HIV viral suppression in pregnancy can experience viral load rebound predelivery.

Aging With HIV: Expert Insights on Complications and Challenges

Aging With HIV: Expert Insights on Complications and Challenges

Three HIV experts provide their insights into aging-related challenges and complications faced by people living with HIV.

HIV Status May Not Effect Incidence of Invasive Cervical Cancer

HIV Status May Not Effect Incidence of Invasive Cervical Cancer

HIV infection may not contribute to incidence of invasive cervical cancer.

FDA Grants Priority Review to Single Tablet HIV Regimen

FDA Grants Priority Review to Single Tablet HIV Regimen

The FDA has granted Priority Review to the New Drug Application for Gilead's investigational single-tablet regimen in the treatment of HIV-1 infection.

Penile Microbiome Linked to Increased HIV Risk in Heterosexual Partners

Penile Microbiome Linked to Increased HIV Risk in Heterosexual Partners

The microbiome of the area on the penis located under the foreskin in uncircumcised straight men has been linked to increased risk for contracting HIV.

Antiretroviral Therapy Associated With Decreases in Bone Mineral Density

Antiretroviral Therapy Associated With Decreases in Bone Mineral Density

Patients with HIV undergoing antiretroviral therapy saw significant decreases in bone mineral density.

Walgreens Expands HIV PrEP Availibility

Walgreens Expands HIV PrEP Availibility

Providers at Walgreens Healthcare Clinics in 17 new locations will be able to prescribe PrEP for HIV prevention.

CDC: No Evidence to Encourage More Frequent HIV Screening in MSM

CDC: No Evidence to Encourage More Frequent HIV Screening in MSM

The CDC systematic review follows a trend of clinicians offering more frequent HIV screening to gay, bisexual, and other men who have sex with men, but the evidence is insufficient to warrant a change to the current recommendations.

New Genvoya Label Includes Safety, Efficacy, Resistance, Drug Interactions

New Genvoya Label Includes Safety, Efficacy, Resistance, Drug Interactions

The FDA has approved labeling changes for Genvoya to include long-term efficacy, safety, resistance data and drug interactions.

SIGN UP FOR FREE E-NEWSLETTERS